(Q44481371)

3 December 2017

title

Calming versus sedative effects of intramuscular olanzapine in agitated patients (English)

1 reference

3 December 2017

0 references

1 reference

John Battaglia

1

1 reference

3 December 2017

Stacy R Lindborg

2

1 reference

3 December 2017

Karla Alaka

3

1 reference

3 December 2017

Karena Meehan

4

1 reference

3 December 2017

Padraig Wright

5

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

American Journal of Emergency Medicine

3 December 2017

published in

1 reference

3 December 2017

volume

21

1 reference

3 December 2017

issue

3

1 reference

3 December 2017

page(s)

192-198

1 reference

3 December 2017

cites work

Rapid Tranquilization

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2802%2942249-8

7 January 2021

Rapid treatment of acute psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2802%2942249-8

7 January 2021

Rapid tranquilization of the violent patient

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2802%2942249-8

7 January 2021

Loxapine versus haloperidol parenterally in acute psychosis with agitation. A double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2802%2942249-8

7 January 2021

Chemical restraint for the agitated patient in the emergency department: lorazepam versus droperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2802%2942249-8

7 January 2021

Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2802%2942249-8

7 January 2021

Respiratory distress with use of lorazepam in mania

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2802%2942249-8

7 January 2021

A risk for obstruction of the airways in the parenteral use of levomepromazine with benzodiazepine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2802%2942249-8

7 January 2021

Pharmacotherapy of borderline personality disorder. Alprazolam, carbamazepine, trifluoperazine, and tranylcypromine.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2802%2942249-8

7 January 2021

Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2802%2942249-8

7 January 2021

A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2802%2942249-8

7 January 2021

Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2802%2942249-8

7 January 2021

Pyramidical model of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2802%2942249-8

7 January 2021

10.1016/S0735-6757(02)42249-8

Identifiers

DOI

1 reference

3 December 2017

1 reference